Obermeyer Wealth Partners’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-12,242
| Closed | -$424K | – | 272 |
|
|
2024
Q2 | $424K | Hold |
12,242
| – | – | 0.02% | 160 |
|
|
2024
Q1 | $354K | Buy |
12,242
+176
| +1% | +$5.09K | 0.02% | 174 |
|
|
2023
Q4 | $277K | Sell |
12,066
-1,726
| -13% | -$39.6K | 0.02% | 183 |
|
|
2023
Q3 | $230K | Buy |
13,792
+1,180
| +9% | +$19.7K | 0.02% | 187 |
|
|
2023
Q2 | $348K | Sell |
12,612
-1,076
| -8% | -$29.7K | 0.03% | 147 |
|
|
2023
Q1 | $315K | Sell |
13,688
-662
| -5% | -$15.2K | 0.02% | 153 |
|
|
2022
Q4 | $157K | Sell |
14,350
-958
| -6% | -$10.5K | 0.01% | 218 |
|
|
2022
Q3 | $129K | Buy |
15,308
+34
| +0.2% | +$287 | 0.01% | 206 |
|
|
2022
Q2 | $121K | Sell |
15,274
-786,351
| -98% | -$6.23M | 0.01% | 199 |
|
|
2022
Q1 | $19M | Buy |
801,625
+12,683
| +2% | +$300K | 1.14% | 29 |
|
|
2021
Q4 | $27M | Buy |
788,942
+12,253
| +2% | +$419K | 1.45% | 29 |
|
|
2021
Q3 | $13.8M | Buy |
776,689
+15,671
| +2% | +$278K | 0.76% | 36 |
|
|
2021
Q2 | $34.2M | Buy |
761,018
+374,946
| +97% | +$16.8M | 1.9% | 30 |
|
|
2021
Q1 | $10M | Buy |
+386,072
| New | +$10M | 0.61% | 39 |
|